We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Kite Pharma announced positive interim results from a Phase II clinical trial of its immunotherapy in patients with aggressive non-Hodgkin’s lymphomas, and said the study would form the basis of its marketing submissions to the FDA. Read More
The Indian government has revised its list of essential medicines, removing price caps on dozens of drugs in a number of therapeutic classes. Read More
Cheng Fong Chemical received a warning letter from the FDA for dirty equipment, poorly maintained facilities and improper investigations into possibly tainted batches of active pharmaceutical ingredients. Read More
A federal appeals court rejected Genzyme’s rehearing request in a lawsuit that alleges the Patent Trial and Appeal Board violated protocol when it invalidated the company’s patent covering treatment methods for a rare muscle disease. Read More
The Center for American Progress has unveiled a plan to create a system for health care payers to negotiate prices based on the clinical benefits of a treatment. Read More